Newnorm
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Newnorm, covering 2025-10-03 to 2026-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases [Phase 3]